OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of NLRP3 Inflammasome and Its Inhibitors as Emerging Therapeutic Drug Candidate for Alzheimer’s Disease: a Review of Mechanism of Activation, Regulation, and Inhibition
Barkha Sharma, Garvit Satija, Anish Madan, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 56-87
Open Access | Times Cited: 36
Barkha Sharma, Garvit Satija, Anish Madan, et al.
Inflammation (2022) Vol. 46, Iss. 1, pp. 56-87
Open Access | Times Cited: 36
Showing 1-25 of 36 citing articles:
Glial Cell-Mediated Neuroinflammation in Alzheimer’s Disease
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 91
Nour F. Al-Ghraiybah, Junwei Wang, Amer E. Alkhalifa, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10572-10572
Open Access | Times Cited: 91
The role of neuroinflammation in neurodegenerative diseases: current understanding and future therapeutic targets
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 89
Alhamdu Adamu, Shuo Li, Fankai Gao, et al.
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 89
Inflammasomes: Mechanisms of Action and Involvement in Human Diseases
Dimitri Bulté, Chiara Rigamonti, Alessandro Pecego Martins Romano, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1766-1766
Open Access | Times Cited: 29
Dimitri Bulté, Chiara Rigamonti, Alessandro Pecego Martins Romano, et al.
Cells (2023) Vol. 12, Iss. 13, pp. 1766-1766
Open Access | Times Cited: 29
Diversity, distribution and role of probiotics for human health: Current research and future challenges
Tawseefa Jan, Rajeshwari Negi, Babita Sharma, et al.
Biocatalysis and Agricultural Biotechnology (2023) Vol. 53, pp. 102889-102889
Closed Access | Times Cited: 23
Tawseefa Jan, Rajeshwari Negi, Babita Sharma, et al.
Biocatalysis and Agricultural Biotechnology (2023) Vol. 53, pp. 102889-102889
Closed Access | Times Cited: 23
Oxidative stress involvement in the molecular pathogenesis and progression of multiple sclerosis: a literature review
Alfredo Sanabria‐Castro, Alberto Alape‐Girón, Marietta Flores‐Díaz, et al.
Reviews in the Neurosciences (2024) Vol. 35, Iss. 3, pp. 355-371
Closed Access | Times Cited: 10
Alfredo Sanabria‐Castro, Alberto Alape‐Girón, Marietta Flores‐Díaz, et al.
Reviews in the Neurosciences (2024) Vol. 35, Iss. 3, pp. 355-371
Closed Access | Times Cited: 10
The emerging role of brain neuroinflammatory responses in Alzheimer’s disease
Mandana Amelimojarad, Melika Amelimojarad, Xiaonan Cui
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 8
Mandana Amelimojarad, Melika Amelimojarad, Xiaonan Cui
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 8
The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets
Melika Amelimojarad, Mandana AmeliMojarad
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 8
Melika Amelimojarad, Mandana AmeliMojarad
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 7
Open Access | Times Cited: 8
Microglial NLRP3 Inflammasomes in Alzheimer’s Disease Pathogenesis: From Interaction with Autophagy/Mitophagy to Therapeutics
Gunel Ayyubova, Leelavathi N. Madhu
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Gunel Ayyubova, Leelavathi N. Madhu
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Role of Peripheral NLRP3 Inflammasome in Cognitive Impairments: Insights of Non-central Factors
Min Qiao, Junjun Ni, Hong Qing, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Min Qiao, Junjun Ni, Hong Qing, et al.
Molecular Neurobiology (2025)
Closed Access | Times Cited: 1
Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer’s disease
Gizem Terzioğlu, Tracy L. Young‐Pearse
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Gizem Terzioğlu, Tracy L. Young‐Pearse
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 22
Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Giacoma Galizzi, Marta Di Carlo
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8586-8606
Open Access | Times Cited: 18
Giacoma Galizzi, Marta Di Carlo
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 8586-8606
Open Access | Times Cited: 18
Pharmacological targets at the lysosomal autophagy–NLRP3 inflammasome crossroads
Srinivasa Reddy Bonam, Dylan Mastrippolito, Philippe Georgel, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 81-101
Closed Access | Times Cited: 14
Srinivasa Reddy Bonam, Dylan Mastrippolito, Philippe Georgel, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 81-101
Closed Access | Times Cited: 14
Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
Oualid Sbai, Veronica Bazzani, Shreya Tapaswi, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
Oualid Sbai, Veronica Bazzani, Shreya Tapaswi, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 11
The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines
Chutikorn Nopparat, Anuttree Boontor, Suchanoot Kutpruek, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
Chutikorn Nopparat, Anuttree Boontor, Suchanoot Kutpruek, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
NLRP3 Inflammasome Inhibitors for Antiepileptogenic Drug Discovery and Development
Inamul Haque, Pritam Thapa, Douglas M. Burns, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6078-6078
Open Access | Times Cited: 4
Inamul Haque, Pritam Thapa, Douglas M. Burns, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6078-6078
Open Access | Times Cited: 4
The research trends and hotspots of NLRP3 inflammasome in Alzheimer's disease: a bibliometric and visualization analysis
Xuanwei Wen, Huiye Yang, Shuangxi Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Xuanwei Wen, Huiye Yang, Shuangxi Chen, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Targeting the NLRP3 inflammasome as a novel therapeutic target for osteoarthritis
Varnita Karmakar, Mayukh Chain, Ankit Majie, et al.
Inflammopharmacology (2025)
Closed Access
Varnita Karmakar, Mayukh Chain, Ankit Majie, et al.
Inflammopharmacology (2025)
Closed Access
Rho GTPases, a Potential Target for the Treatment of Neurodegenerative Disorders and the Neuroprotective Effect of Statins as a Rho GTPase Inhibitor
Hala M. Alkhalidi
International Journal of Pharmacology (2025) Vol. 21, Iss. 1, pp. 1-15
Closed Access
Hala M. Alkhalidi
International Journal of Pharmacology (2025) Vol. 21, Iss. 1, pp. 1-15
Closed Access
Virtual screening, molecular docking simulation and ADMET prediction of some selected natural products as potential inhibitors of NLRP3 inflammasomes as drug candidates for Alzheimer disease
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Biocatalysis and Agricultural Biotechnology (2023) Vol. 48, pp. 102615-102615
Closed Access | Times Cited: 9
Abduljelil Ajala, Adamu Uzairu, Gideon Adamu Shallangwa, et al.
Biocatalysis and Agricultural Biotechnology (2023) Vol. 48, pp. 102615-102615
Closed Access | Times Cited: 9
NLRP3/1-mediated pyroptosis: beneficial clues for the development of novel therapies for Alzheimer’s disease
Bo Hu, Ping Zhang, Jie Huang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 11, pp. 2400-2410
Open Access | Times Cited: 9
Bo Hu, Ping Zhang, Jie Huang, et al.
Neural Regeneration Research (2023) Vol. 19, Iss. 11, pp. 2400-2410
Open Access | Times Cited: 9
Targeting NLRP3 Inflammasomes: A Trojan Horse Strategy for Intervention in Neurological Disorders
Mohammad Amin Bayat Tork, Soroush Fotouhi, Parvin Roozi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Mohammad Amin Bayat Tork, Soroush Fotouhi, Parvin Roozi, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 3
Therapeutic role of NLRP3 inflammasome inhibitors against Alzheimer’s disease
Tanmoy Tantra, Abdul Rahaman T A, Nandini Nandini, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107912-107912
Closed Access | Times Cited: 3
Tanmoy Tantra, Abdul Rahaman T A, Nandini Nandini, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107912-107912
Closed Access | Times Cited: 3
Essential oil and polyphenolics from Thymus satureioides Coss. counteract acrylamide-induced liver toxicity through suppression of NLRP3 inflammasome/NF-κB axis
Mona F. Mahmoud, Rania A. Elrashidy, Heba Osama Mohammed, et al.
Journal of Functional Foods (2023) Vol. 107, pp. 105641-105641
Open Access | Times Cited: 8
Mona F. Mahmoud, Rania A. Elrashidy, Heba Osama Mohammed, et al.
Journal of Functional Foods (2023) Vol. 107, pp. 105641-105641
Open Access | Times Cited: 8
Potential Alzheimer’s disease drug targets identified through microglial biology research
Izabela Lepiarz‐Raba, Taufik Hidayat, Anthony J. Hannan, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 5, pp. 587-602
Closed Access | Times Cited: 2
Izabela Lepiarz‐Raba, Taufik Hidayat, Anthony J. Hannan, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 5, pp. 587-602
Closed Access | Times Cited: 2
Mitochondrial dysfunction and inflammasome activation in neurodegenerative diseases: Mechanisms and therapeutic implications
Olia Hamzeh, Fatemeh Rabiei, Mahdi Shakeri, et al.
Mitochondrion (2023) Vol. 73, pp. 72-83
Closed Access | Times Cited: 6
Olia Hamzeh, Fatemeh Rabiei, Mahdi Shakeri, et al.
Mitochondrion (2023) Vol. 73, pp. 72-83
Closed Access | Times Cited: 6
